OTCMKTS:BVNRY - BAVARIAN NORDIC/S Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding BAVARIAN NORDIC/S Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $12.25 +1.79 (+17.11 %) (As of 02/23/2020 02:59 PM ET) Add Compare Today's Range$12.25Now: $12.25▼$12.2550-Day Range$8.34MA: $9.75▼$12.2552-Week Range$6.42Now: $12.25▼$12.25Volume3,000 shsAverage Volume223 shsMarket Capitalization$1.19 billionP/E RatioN/ADividend YieldN/ABeta0.52 ProfileAdvanced ChartEarningsHeadlinesSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Bavarian Nordic A/S, a biotechnology company, develops, manufactures, and commercializes a portfolio of cancer immunotherapies and vaccines for infectious diseases. The company markets non-replicating smallpox vaccine under the IMVAMUNE and IMVANEX names. It is also developing MVA-BN RSV, which is in Phase II clinical trials development stage for the prevention of respiratory syncytial virus; MVA-BN Filo that is in Phase III clinical trials for the treatment of Ebola and Marburg; and MVA-BN HPV that is in Phase I/IIa clinical trials to treat human papillomavirus. Read More… Industry, Sector and Symbol Stock Exchange OTCMKTS Industry Biological products, except diagnostic Sub-IndustryN/A SectorMedical Current SymbolOTCMKTS:BVNRY Previous Symbol CUSIPN/A CIKN/A Webhttp://www.bavarian-nordic.com/ Phone45-3326-8383Debt Debt-to-Equity Ratio0.24 Current Ratio7.43 Quick Ratio7.08Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$79.30 million Price / Sales14.97 Cash FlowN/A Price / Cash FlowN/A Book Value$3.56 per share Price / Book3.44Profitability EPS (Most Recent Fiscal Year)($0.59) Net Income$-57,330,000.00 Net Margins-72.61% Return on Equity-19.55% Return on Assets-14.39%Miscellaneous Employees419 Outstanding Shares96,930,000Market Cap$1.19 billion Next Earnings Date3/19/2020 (Estimated) OptionableNot Optionable Receive BVNRY News and Ratings via Email Sign-up to receive the latest news and ratings for BVNRY and its competitors with MarketBeat's FREE daily newsletter. OTC:BVNRY Rates by TradingView BAVARIAN NORDIC/S (OTCMKTS:BVNRY) Frequently Asked Questions What is BAVARIAN NORDIC/S's stock symbol? BAVARIAN NORDIC/S trades on the OTCMKTS under the ticker symbol "BVNRY." When is BAVARIAN NORDIC/S's next earnings date? BAVARIAN NORDIC/S is scheduled to release their next quarterly earnings announcement on Thursday, March 19th 2020. View Earnings Estimates for BAVARIAN NORDIC/S. Has BAVARIAN NORDIC/S been receiving favorable news coverage? Media stories about BVNRY stock have been trending negative recently, according to InfoTrie Sentiment. InfoTrie scores the sentiment of press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. BAVARIAN NORDIC/S earned a coverage optimism score of -2.4 on InfoTrie's scale. They also assigned media coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the immediate future. View News Stories for BAVARIAN NORDIC/S. Who are some of BAVARIAN NORDIC/S's key competitors? Some companies that are related to BAVARIAN NORDIC/S include China Biologic Products (CBPO), bluebird bio (BLUE), Spark Therapeutics (ONCE), Adaptive Biotechnologies (ADPT), Ablynx (ABLYF), Crispr Therapeutics (CRSP), Momenta Pharmaceuticals (MNTA), Halozyme Therapeutics (HALO), Iovance Biotherapeutics (IOVA), Allogene Therapeutics (ALLO), Audentes Therapeutics (BOLD), Denali Therapeutics (DNLI), Fate Therapeutics (FATE), Alector (ALEC) and Regenxbio (RGNX). What other stocks do shareholders of BAVARIAN NORDIC/S own? Based on aggregate information from My MarketBeat watchlists, some companies that other BAVARIAN NORDIC/S investors own include Genmab A/S (GNMSF), Centerstate Bank (CSFL), Denny's (DENN), Unity Biotechnology (UBX), Acceleron Pharma (XLRN), AC Immune (ACIU), Automatic Data Processing (ADP), Aimmune Therapeutics (AIMT), ArQule (ARQL) and BioCryst Pharmaceuticals (BCRX). Who are BAVARIAN NORDIC/S's key executives? BAVARIAN NORDIC/S's management team includes the folowing people: Dr. Paul Chaplin, CEO & Pres (Age 52)Mr. Henrik Juuel, CFO & Exec. VP (Age 54)Mr. Henrik Birk, COO & Exec. VP (Age 45)Dr. Tommi Kainu, Exec. VP & Chief Bus. Officer (Age 46)Dr. Christopher R. Heery, Chief Medical Officer How do I buy shares of BAVARIAN NORDIC/S? Shares of BVNRY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab. What is BAVARIAN NORDIC/S's stock price today? One share of BVNRY stock can currently be purchased for approximately $12.25. How big of a company is BAVARIAN NORDIC/S? BAVARIAN NORDIC/S has a market capitalization of $1.19 billion and generates $79.30 million in revenue each year. The company earns $-57,330,000.00 in net income (profit) each year or ($0.59) on an earnings per share basis. BAVARIAN NORDIC/S employs 419 workers across the globe.View Additional Information About BAVARIAN NORDIC/S. What is BAVARIAN NORDIC/S's official website? The official website for BAVARIAN NORDIC/S is http://www.bavarian-nordic.com/. How can I contact BAVARIAN NORDIC/S? BAVARIAN NORDIC/S's mailing address is Hejreskovvej 10A, Kvistgaard G7, 3490. The company can be reached via phone at 45-3326-8383 or via email at [email protected] MarketBeat Community Rating for BAVARIAN NORDIC/S (OTCMKTS BVNRY)Community Ranking: 2.8 out of 5 ( )Outperform Votes: 175 (Vote Outperform)Underperform Votes: 143 (Vote Underperform)Total Votes: 318MarketBeat's community ratings are surveys of what our community members think about BAVARIAN NORDIC/S and other stocks. Vote "Outperform" if you believe BVNRY will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BVNRY will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 2/23/2020 by MarketBeat.com StaffFeatured Article: Why are percentage decliners important?
